Early IFN-gamma production after YF 17D vaccine virus immunization in mice and its association with adaptive immune responses

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Neves, Patrícia C C ^a   Santos, Juliana R ^b   Tubarão, Luciana N ^b   Bonaldo, Myrna C ^b   Galler, Ricardo ^a  

^a Instituto de Technologia em Imunobiologicos   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; YELLOW FEVER VACCINE;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL LINEAGE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; GAMMA DELTA T LYMPHOCYTE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; INNATE IMMUNITY; MOUSE; NATURAL KILLER CELL; NONHUMAN; VIRUS NEUTRALIZATION; YELLOW FEVER;

ADAPTIVE IMMUNITY; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODY FORMATION; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CERCOPITHECUS AETHIOPS; FEMALE; GENE PRODUCTS, GAG; HUMANS; IMMUNIZATION; IMMUNOGLOBULIN G; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LYMPH NODES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RECOMBINATION, GENETIC; SPLEEN; VERO CELLS; YELLOW FEVER; YELLOW FEVER VACCINE; YELLOW FEVER VIRUS;

EID: 84891949728     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081953     Document Type: Article

References (73)

1. Barrett A D T, Teuwen DE (2009) Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place? Curr Opin Immunol 21:308-313. doi:10.1016/j.coi.2009.05.018. PubMed: 19520559.
2. Pulendran B (2009) Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology. Nat Rev Immunol 9:741-747. doi:10.1038/nri2629. PubMed: 19763148.
3. Barba-Spaeth G, Longman RS, Albert ML, Rice CM (2005) Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes. J Exp Med 202:1179-1184. doi:10.1084/jem.20051352. PubMed: 16260489. (Pubitemid 41586948)
4. Querec T, Bennouna S, Alkan S, Laouar Y, Gorden K et al. (2006) Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J Exp Med 203:413-424. doi:10.1084/jem.20051720. PubMed: 16461338. (Pubitemid 43290850)
5. Querec TD, Akondy RS, Lee EK, Cao W, Nakaya HI et al. (2009) Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat Immunol 10:116-125. doi:10.1038/ni.1688. PubMed: 19029902.
6. Gaucher D, Therrien R, Kettaf N, Angermann BR, Boucher G et al. (2008) Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J Exp Med 205:3119-3131. doi: 10.1084/jem.20082292. PubMed: 19047440.
7. Neves PC, da C, Matos DC, de S, Marcovistz R, Galler R (2009) TLR expression and NK cell activation after human yellow fever vaccination. Vaccine 27:5543-5549. doi:10.1016/j.vaccine.2009.07.028. PubMed: 19647065.
8. Neves P C C, Rudersdorf RA, Galler R, Bonaldo MC, de Santana M G V et al. (2010) CD8+ gamma-delta TCR+ and CD4+ T cells produce IFN-γ at 5-7 days after yellow fever vaccination in Indian rhesus macaques, before the induction of classical antigen-specific T cell responses. Vaccine 28:8183-8188. doi:10.1016/j.vaccine.2010.09.090. PubMed: 20939995.
9. Liu T, Nishimura H, Matsuguchi T, Yoshikai Y (2000) Differences in interleukin-12 and -15 production by dendritic cells at the early stage of Listeria monocytogenes infection between BALB/c and C57 BL/6 mice. Cell Immunol 202:31-40. doi:10.1006/cimm.2000.1644. PubMed: 10873304. (Pubitemid 30445644)
10. Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM (2000) M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol 164:6166-6173. PubMed: 10843666. (Pubitemid 30408793)
11. Watanabe H, Numata K, Ito T, Takagi K, Matsukawa A (2004) Innate immune response in Th1- and Th2-dominant mouse strains. Shock 22:460-466. doi:10.1097/01.shk.0000142249.08135.e9. PubMed: 15489639. (Pubitemid 39472571)
12. Bou Ghanem EN, Nelson CC, D'Orazio S E F (2011) T cell-intrinsic factors contribute to the differential ability of CD8+ T cells to rapidly secrete IFN-γ in the absence of antigen. J Immunol 186:1703-1712. doi:10.4049/jimmunol.1001960. PubMed: 21191063.
13. Berg RE, Crossley E, Murray S, Forman J (2003) Memory CD8+ T cells provide innate immune protection against Listeria monocytogenes in the absence of cognate antigen. J Exp Med 198:1583-1593. doi: 10.1084/jem.20031051. PubMed: 14623912. (Pubitemid 37467172)
14. Miller JD, van der Most RG, Akondy RS, Glidewell JT, Albott S et al. (2008) Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. Immunity 28:710-722. doi:10.1016/j.immuni.2008.02.020. PubMed: 18468462.
15. Bonaldo MC, Martins MA, Rudersdorf R, Mudd PA, Sacha JB et al. (2010) Recombinant yellow fever vaccine virus 17D expressing simian immunodeficiency virus SIVmac239 gag induces SIV-specific CD8+ Tcell responses in rhesus macaques. J Virol 84:3699-3706. doi: 10.1128/JVI.02255-09. PubMed: 20089645.
16. Bonaldo MC, Mello SM, Trindade GF, Rangel AA, Duarte AS et al. (2007) Construction and characterization of recombinant flaviviruses bearing insertions between E and NS1 genes. Virol J 4:115. doi: 10.1186/1743-422X-4-115. PubMed: 17971212.
17. Weill L, James L, Ulryck N, Chamond N, Herbreteau CH et al. (2010) A new type of IRES within gag coding region recruits three initiation complexes on HIV-2 genomic RNA. Nucleic Acids Res 38:1367-1381. doi:10.1093/nar/gkp1109. PubMed: 19969542.
18. Maciel M Jr, Kellathur SN, Chikhlikar P, Dhalia R, Sidney J et al. (2008) Comprehensive analysis of T cell epitope discovery strategies using 17DD yellow fever virus structural proteins and BALB/c (H2d) mice model. Virology 378:105-117. doi:10.1016/j.virol.2008.04.043. PubMed: 18579176.
19. Singh R, Rothman AL, Potts J, Guirakhoo F, Ennis FA et al. (2010) Sequential immunization with heterologous chimeric flaviviruses induces broad-spectrum cross-reactive CD8+ T cell responses. J Infect Dis 202:223-233. doi:10.1086/653486. PubMed: 20536361.
20. Stefano I, Sato HK, Pannuti CS, Omoto TM, Mann G et al. (1999) Recent immunization against measles does not interfere with the seroresponse to yellow fever vaccine. Vaccine 17:1042-1046. doi:10.1016/S0264-410X (98) 00320-X. PubMed: 10195613. (Pubitemid 29132935)
21. Lieberman LA, Hunter CA (2002) Regulatory pathways involved in the infection-induced production of IFN-gamma by NK cells. Microbes Infect 4:1531-1538. doi:10.1016/S1286-4579 (02) 00036-9. PubMed: 12505525. (Pubitemid 36050822)
22. Fang H, Welte T, Zheng X, Chang G-JJ, Holbrook MR et al. (2010) gammadelta T cells promote the maturation of dendritic cells during West Nile virus infection. FEMS Immunol Med Microbiol 59:71-80. doi: 10.1111/j.1574-695X. 2010.00663.x. PubMed: 20337718.
23. Martín-Fontecha A, Thomsen LL, Brett S, Gerard C, Lipp M et al. (2004) Induced recruitment of NK cells to lymph nodes provides IFNgamma for T (H) 1 priming. Nat Immunol 5:1260-1265. doi:10.1038/ni1138. PubMed: 15531883. (Pubitemid 41057741)
24. Wiesel M, Oxenius A (2012) From crucial to negligible: functional CD8+ T-cell responses and their dependence on CD4+ T-cell help. Eur J Immunol 42:1080-1088. doi:10.1002/eji.201142205. PubMed: 22539281.
25. Billiau A, Matthys P (2009) Interferon-gamma: a historical perspective. Cytokine Growth Factor Rev 20:97-113. doi:10.1016/j.cytogfr. 2009.02.004. PubMed: 19268625.
26. Schoenborn JR, Wilson CB (2007) Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol 96:41-101. doi:10.1016/S0065-2776 (07) 96002-2. PubMed: 17981204. (Pubitemid 350018717)
27. Wehner R, Dietze K, Bachmann M, Schmitz M (2011) The bidirectional crosstalk between human dendritic cells and natural killer cells. J Innate Immun 3:258-263. doi:10.1159/000323923. PubMed: 21411969.
28. Julander JG, Trent DW, Monath TP (2011) Immune correlates of protection against yellow fever determined by passive immunization and challenge in the hamster model. Vaccine 29:6008-6016. doi: 10.1016/j.vaccine.2011.06.034. PubMed: 21718741.
29. Kasturi SP, Skountzou I, Albrecht RA, Koutsonanos D, Hua T et al. (2011) Programming the magnitude and persistence of antibody responses with innate immunity. Nature 470:543-547. doi:10.1038/nature09737. PubMed: 21350488.
30. Burton DR (2002) Antibodies, viruses and vaccines. Nat Rev Immunol 2:706-713. doi:10.1038/nri891. PubMed: 12209139. (Pubitemid 37328728)
31. Nimmerjahn F, Ravetch JV (2008) Fcgamma receptors as regulators of immune responses. Nat Rev Immunol 8:34-47. doi:10.1038/nri2206. PubMed: 18064051.
32. Liblau RS, Singer SM, McDevitt HO (1995) Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 16:34-38. doi:10.1016/0167-5699 (95) 80068-9. PubMed: 7880387.
33. Dittmer U, Peterson KE, Messer R, Stromnes IM, Race B et al. (2001) Role of interleukin-4 (IL-4), IL-12, and gamma interferon in primary and vaccine-primed immune responses to Friend retrovirus infection. J Virol 75:654-660. doi:10.1128/JVI.75.2.654-660.2001. PubMed: 11134279. (Pubitemid 32037269)
34. Santos AP, Matos D C S, Bertho AL, Mendonca S C F, Marcovistz R (2008) Detection of Th1/Th2 cytokine signatures in yellow fever 17DD first-time vaccinees through ELISpot assay. Cytokine 42:152-155. doi: 10.1016/j.cyto.2008. 02.007. PubMed: 18378159.
35. Hoft DF, Lynch RG, Kirchhoff LV (1993) Kinetic analysis of antigenspecific immune responses in resistant and susceptible mice during infection with Trypanosoma cruzi. J Immunol 151:7038-7047. PubMed: 8258708. (Pubitemid 24001078)
36. Antunez MI, Cardoni RL (2001) Early IFN-gamma production is related to the presence of interleukin (IL)-18 and the absence of IL-13 in experimental Trypanosoma cruzi infections. Immunol Lett 79:189-196. doi:10.1016/S0165-2478 (01) 00283-8. PubMed: 11600197. (Pubitemid 32971892)
37. Gandini M, Reis S R N I, Torrentes-Carvalho A, Azeredo EL, Freire MdaS, da S et al. (2011) Dengue-2 and yellow fever 17DD viruses infect human dendritic cells, resulting in an induction of activation markers, cytokines and chemokines and secretion of different TNF-α and IFN-α profiles. Mem Inst Oswaldo Cruz 106:594-605. doi:10.1590/S0074-02762011000500012. PubMed: 21894381.
38. Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT et al. (2011) A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472:481-485. doi:10.1038/nature09907. PubMed: 21478870.
39. Munoz-Jordan JL, Laurent-Rolle M, Ashour J, Martinez-Sobrido L, Ashok M et al. (2005) Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J Virol 79:8004-8013. doi:10.1128/JVI. 79.13.8004-8013.2005. PubMed: 15956546. (Pubitemid 40853504)
40. Martino A, Poccia F (2007) Gamma delta T cells and dendritic cells: close partners and biological adjuvants for new therapies. Curr Mol Med 7:658-673. doi:10.2174/156652407782564345. PubMed: 18045144. (Pubitemid 350201666)
41. Beetz S, Wesch D, Marischen L, Welte S, Oberg H-H et al. (2008) Innate immune functions of human gammadelta T cells. Immunobiology 213:173-182. doi:10.1016/j.imbio.2007.10.006. PubMed: 18406365. (Pubitemid 351484782)
42. Casetti R, Martino A (2008) The plasticity of gamma delta T cells: innate immunity, antigen presentation and new immunotherapy. Cell Mol Immunol 5:161-170. doi:10.1038/cmi.2008.20. PubMed: 18582397.
43. Lauzon NM, Mian F, MacKenzie R, Ashkar AA (2006) The direct effects of Toll-like receptor ligands on human NK cell cytokine production and cytotoxicity. Cell Immunol 241:102-112. doi:10.1016/j.cellimm. 2006.08.004. PubMed: 17049504. (Pubitemid 44648026)
44. Sivori S, Falco M, Della Chiesa M, Carlomagno S, Vitale M et al. (2004) CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc Natl Acad Sci U S A 101:10116-10121. doi: 10.1073/pnas.0403744101. PubMed: 15218108. (Pubitemid 38891204)
45. Devilder M-C, Allain S, Dousset C, Bonneville M, Scotet E (2009) Early triggering of exclusive IFN-gamma responses of human Vgamma9Vdelta2 T cells by TLR-activated myeloid and plasmacytoid dendritic cells. J Immunol 183:3625-3633. doi:10.4049/jimmunol. 0901571. PubMed: 19710464.
46. Wang T, Scully E, Yin Z, Kim JH, Wang S et al. (2003) IFN-γ-Producing γδ T Cells Help Control Murine West Nile Virus. Infection - J Immunol 171:2524-2531. (Pubitemid 37025562)
47. Ryan EJ, Harenberg A, Burdin N (2007) The Canarypox-virus vaccine vector ALVAC triggers the release of IFN-gamma by Natural Killer (NK) cells enhancing Th1 polarization. Vaccine 25:3380-3390. doi:10.1016/j.vaccine.2006.12.048. PubMed: 17234309. (Pubitemid 46534012)
48. Soulard V, Roland J, Gorgette O, Barbier E, Cazenave P-A et al. (2009) An early burst of IFN-gamma induced by the pre-erythrocytic stage favours Plasmodium yoelii parasitaemia in B6 mice. Malar J 8:128. doi:10.1186/1475-2875- 8-128. PubMed: 19508725.
49. Park SJ, Hughes MA, Burdick M, Strieter RM, Mehrad B (2009) Early NK cell-derived IFN-{gamma} is essential to host defense in neutropenic invasive aspergillosis. J Immunol 182:4306-4312. doi: 10.4049/jimmunol.0803462. PubMed: 19299730.
50. D'Orazio S E F, Troese MJ, Starnbach MN (2006) Cytosolic localization of Listeria monocytogenes triggers an early IFN-gamma response by CD8+ T cells that correlates with innate resistance to infection. J Immunol 177:7146-7154. PubMed: 17082632. (Pubitemid 44715083)
51. Liu T, Chambers TJ (2001) Yellow fever virus encephalitis: properties of the brain-associated T-cell response during virus clearance in normal and gamma interferon-deficient mice and requirement for CD4+ lymphocytes. J Virol 75:2107-2118. doi:10.1128/JVI. 75.5.2107-2118.2001. PubMed: 11160715. (Pubitemid 32147550)
52. Liu S-Y, Sanchez DJ, Aliyari R, Lu S, Cheng G (2012) Systematic identification of type I and type II interferon-induced antiviral factors. Proc Natl Acad Sci U S A 109:4239-4244. doi:10.1073/pnas. 1114981109. PubMed: 22371602.
53. Siegers GM, Dhamko H, Wang X-H, Mathieson AM, Kosaka Y et al. (2011) Human Vδ1 γδ T cells expanded from peripheral blood exhibit specific cytotoxicity against B-cell chronic lymphocytic leukemia-derived cells. Cytotherapy 13:753-764. doi:10.3109/14653249.2011.553595. PubMed: 21314241.
54. Qin G, Mao H, Zheng J, Sia SF, Liu Y et al. (2009) Phosphoantigenexpanded human gammadelta T cells display potent cytotoxicity against monocyte-derived macrophages infected with human and avian influenza viruses. J Infect Dis 200:858-865. doi:10.1086/605413. PubMed: 19656068.
55. Tu W, Zheng J, Liu Y, Sia SF, Liu M et al. (2011) The aminobisphosphonate pamidronate controls influenza pathogenesis by expanding a gammadelta T cell population in humanized mice. J Exp Med 208:1511-1522. doi:10.1084/jem.20110226. PubMed: 21708931.
56. Quaresma J A S, Barros V L R S, Pagliari C, Fernandes ER, Guedes F et al. (2006) Revisiting the liver in human yellow fever: virus-induced apoptosis in hepatocytes associated with TGF-beta, TNF-alpha and NK cells activity. Virology 345:22-30. doi:10.1016/j.virol.2005.09.058. PubMed: 16278000. (Pubitemid 43107570)
57. Chan RC, Penney DJ, Little D, Carter IW, Roberts JA et al. (2001) Hepatitis and death following vaccination with 17D-204 yellow fever vaccine. Lancet 358:121-122. doi:10.1016/S0140-6736 (01) 05341-7. PubMed: 11463415. (Pubitemid 32709852)
58. Neves-Souza P C F, Azeredo EL, Zagne S M O, Valls-de-Souza R, SRNI et al Reis. (2005) Inducible nitric oxide synthase (iNOS) expression in monocytes during acute Dengue Fever in patients and during in vitro infection. BMC Infect Dis 5:64. doi:10.1186/1471-2334-5-64. PubMed: 16109165.
59. Fagundes CT, Costa VV, Cisalpino D, Amaral FA, Souza P R S et al. (2011) IFN-γ production depends on IL-12 and IL-18 combined action and mediates host resistance to dengue virus infection in a nitric oxidedependent manner. PLoS Negl Trop. Drosophila Inf Service 5:e1449. doi:10.1371/journal.pntd. 0001449.
60. Martins MA, Silva ML, Eloi-Santos SM, Ribeiro J G L, Peruhype-Magalhaes V et al. (2008) Innate immunity phenotypic features point toward simultaneous raise of activation and modulation events following 17DD live attenuated yellow fever first-time vaccination. Vaccine 26:1173-1184. doi:10.1016/j.vaccine.2007. 12.035. PubMed: 18243433.
61. Ismaili J, Olislagers V, Poupot R, Fournie J-J, Goldman M (2002) Human gamma delta T cells induce dendritic cell maturation. Clin Immunol 103:296-302. doi:10.1006/clim.2002.5218. PubMed: 12173304. (Pubitemid 34666753)
62. Conti L, Casetti R, Cardone M, Varano B, Martino A et al. (2005) Reciprocal activating interaction between dendritic cells and pamidronate-stimulated gammadelta T cells: role of CD86 and inflammatory cytokines. J Immunol 174:252-260. PubMed: 15611247. (Pubitemid 40007411)
63. Münz C, Steinman RM, Fujii S (2005) Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity. J Exp Med 202:203-207. doi:10.1084/jem.20050810. PubMed: 16027234. (Pubitemid 41043815)
64. Verhoeven D, Teijaro JR, Farber DL (2008) Heterogeneous memory T cells in antiviral immunity and immunopathology. Viral Immunol 21:99-113. doi:10.1089/vim.2007.0002. PubMed: 18476772. (Pubitemid 351873360)
65. Kohler S, Bethke N, Böthe M, Sommerick S, Frentsch M et al. (2012) The early cellular signatures of protective immunity induced by live viral vaccination. Eur J Immunol 42:2363-2373. doi:10.1002/eji.201142306. PubMed: 22733156.
66. Zhou L, Chong M M W, Littman DR (2009) Plasticity of CD4+ T cell lineage differentiation. Immunity 30:646-655. doi:10.1016/j.immuni. 2009.05.001. PubMed: 19464987.
67. Gunther VJ, Putnak R, Eckels KH, Mammen MP, Scherer JM et al. (2011) A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illness. Vaccine 29:3895-3904. doi:10.1016/j.vaccine.2011.03.038. PubMed: 21443963.
68. Bonaldo MC, Caufour PS, Freire MS, Galler R (2000) The yellow fever 17D vaccine virus as a vector for the expression of foreign proteins: development of new live flavivirus vaccines. Mem Inst Oswaldo Cruz 95 Suppl 1:215-223. doi:10.1590/S0074-02762000000700037. PubMed: 11142718.
69. Nogueira RT, Nogueira AR, Pereira M C S, Rodrigues MM, Neves PC, da C et al. (2013) Recombinant yellow fever viruses elicit CD8+ T cell responses and protective immunity against Trypanosoma cruzi. PLOS ONE 8:e59347. doi:10.1371/journal.pone.0059347. PubMed: 23527169.
70. Bachmann MF, Jennings GT (2010) Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat Rev Immunol 10:787-796. doi:10.1038/nri2868. PubMed: 20948547.
71. Dowd KA, Pierson TC (2011) Antibody-mediated neutralization of flaviviruses: a reductionist view. Virology 411:306-315. doi:10.1016/j.virol. 2010.12.020. PubMed: 21255816.
72. Schlesinger JJ, Chapman S (1995) Neutralizing F (ab') 2 fragments of protective monoclonal antibodies to yellow fever virus (YF) envelope protein fail to protect mice against lethal YF encephalitis. J Gen Virol 76(1):217-220. doi:10.1099/0022-1317-76-1-217.
73. Schlesinger JJ, Foltzer M, Chapman S (1993) The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice. Virology 192:132-141. doi:10.1006/viro.1993.1015. PubMed: 8517015.